Cargando…
Drug delivery system for the extended-release of larotrectinib based on a biocompatible Fe-based metal-organic framework: synthesis, characterization, in vitro release properties and antitumor evaluation
Larotrectinib (Lar) is an orally administered tropomyosin receptor kinase (Trk) inhibitor with broad-spectrum antitumor activity that is available in clinical dosage forms as capsules and oral solutions. Currently, corresponding research is focused on developing new extended-release formulation syst...
Autores principales: | Gan, Lu, Ji, Peng, Zhang, Jin-xiang, Chen, Hao, Yao, Yan-sheng, Ren, Zhen-kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267385/ https://www.ncbi.nlm.nih.gov/pubmed/37324434 http://dx.doi.org/10.3389/fbioe.2023.1197484 |
Ejemplares similares
-
Development of Metal-Organic Framework-Based Dual Antibody Nanoparticles for the Highly Specific Capture and Gradual Release of Circulating Tumor Cells
por: Hu, Mingchao, et al.
Publicado: (2022) -
Bioengineered Human Stromal Lenticule for Recombinant Human Nerve Growth Factor Release: A Potential Biocompatible Ocular Drug Delivery System
por: Mastropasqua, Leonardo, et al.
Publicado: (2022) -
Input Estimation for Extended-Release Formulations Exemplified with Exenatide
por: Trägårdh, Magnus, et al.
Publicado: (2017) -
A Simple in vivo Assay Using Amphipods for the Evaluation of Potential Biocompatible Metal-Organic Frameworks
por: Sifaoui, Ines, et al.
Publicado: (2021) -
Surface Modification of Polycaprolactone Scaffold With Improved Biocompatibility and Controlled Growth Factor Release for Enhanced Stem Cell Differentiation
por: Qin, Xiaoyan, et al.
Publicado: (2022)